HOME > Projects > Immunity and Regeneration Integration Unit

A-21

Immunity and Regeneration Integration Unit

6F

0604

New drugs for refractory neurological diseases through translational research

・Search for biomarkers of the state of refractory neurological diseases and effect of drug treatment

・Basic research on drug development for refractory neurological diseases

・Search for new drug targets in refractory neurological diseases

Frustratingly, little is known about the causes of many neurological diseases and little is available in terms of treatment. In this course, we examine the pathology of several neurological diseases, the use of animal models to study the disease, and consider potential drug targets and biomarkers. Studies involve basic and clinical research.

Responsible Department

Department of Neuro-Medical Science

Research Partner

Mitsubishi Tanabe Pharma Corporation

Project Members

Principal Investigator

YAMASHITA Toshihide

Professor

Department of Molecular Neuroscience

Profile

 

ITOKAZU Takahide

Specially Appointed Professor

Department of Neuro-Medical Science

Profile

Members

OHTAKE Yosuke

Specially Appointed Assistant Professor

Department of Neuro-Medical Science

Profile
NAKANISHI Toru

Specially Appointed Assistant Professor

Department of Neuro-Medical Science

Profile
ISHIKURA Teruyuki

Specially Appointed Assistant Professor

Department of Neuro-Medical Science

Profile
UEDA Tsubasa

Specially Appointed Researcher

Department of Neuro-Medical Science

Profile
KATAOKA Hirotoshi

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

TANAKA Shinji

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

SAKAUE Masaki

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

MIWA Keiko

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

SANTOH Masataka

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

SEKINE Misuzu

Joint Research Collaborator

Mitsubishi Tanabe Pharma Corporation

←back